Press Release

UAE Glucometers Market to grow at CAGR of 9.94% to 2028

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Glucometers Market.

According to TechSci Research report, “UAE Glucometers Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, UAE Glucometers Market has valued at USD 0.17 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 9.94% through 2028. This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position.

Consumer preferences for wearable devices have been a significant driver of the demand for glucometers. Wearable glucometers offer the convenience of continuous monitoring without the need for frequent manual testing. The portability of these devices allows users to carry them easily, promoting regular monitoring anytime and anywhere. Wearable glucometers provide real-time data on blood glucose levels, allowing users to access information instantly. This real-time feedback is valuable for making immediate decisions about insulin dosage, dietary choices, and lifestyle modifications. Many wearable glucometers seamlessly integrate with smartphones, smartwatches, or other smart devices. This integration allows users to monitor their glucose levels through dedicated apps, receive notifications, and synchronize data with other health and fitness applications. Wearable glucometers are often designed with user convenience in mind. Intuitive interfaces, simple controls, and easy-to-understand data displays cater to the preferences of consumers who value a user-friendly experience.

Wearable glucometers may offer additional health and fitness tracking features beyond glucose monitoring. The integration of multiple health metrics, such as activity levels and sleep patterns, appeals to consumers who prioritize a comprehensive approach to health monitoring. Wearable glucometers often come with customizable settings and features, allowing users to personalize their monitoring experience. Consumers appreciate devices that can be tailored to their individual preferences and health goals.


Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Glucometers Market


In February 2023, EOFlow Co., Ltd. has announced that its Gulf Cooperation Council (GCC) partner, GulfDrug LLC (Gulf Drug) in the United Arab Emirates (UAE), has officially introduced the EOPatch Insulin Management System. This tubeless, wearable, and disposable insulin pump offers an alternative to conventional insulin delivery methods. The system includes a patch that can be worn, and a dedicated controller named ADM, or a smartphone app called Narsha. It enables continuous insulin delivery for effective blood glucose control. The wearable design of the patch allows for up to three and a half days (84 hours) of continuous insulin delivery, with a convenient twice-a-week replacement cycle, enhancing user compliance.

Educational barriers can pose a challenge in the UAE glucometers market. Some individuals may have limited health literacy, meaning they may struggle to understand health-related information, including the significance of blood glucose monitoring. This can hinder their ability to use glucometers effectively. Insufficient availability of structured diabetes education programs can contribute to a lack of awareness about the importance of regular blood glucose monitoring. Comprehensive education can empower individuals to take charge of their diabetes management. Language differences among the diverse population in the UAE can be a barrier to effective communication about diabetes and glucometer usage. Educational materials and programs need to be accessible in multiple languages to reach a broader audience. Cultural beliefs and perceptions of health may influence individuals' attitudes toward diabetes management and monitoring. Tailoring educational materials to align with cultural norms and values is essential for effective communication. Stigma surrounding diabetes may deter individuals from seeking information or support. Educational campaigns that address and counteract diabetes-related stigma can create a more supportive environment for those managing the condition.

UAE Glucometers Market is segmented based on Product Type, Technique, Type, Distribution Channel, End User, and by region.  

Based on the Technique, UAE Glucometers Market is segmented into Invasive, Non-Invasive. Invasive glucometers are devices used for measuring blood glucose levels through the extraction of a small blood sample, typically obtained through a fingerstick or another minimally invasive method. These devices are commonly used by individuals with diabetes to monitor their blood glucose levels regularly. An invasive glucometer system includes a lancing device, which is a small handheld instrument used to puncture the skin and obtain a tiny drop of blood. The lancing device often contains a spring-loaded mechanism that quickly pricks the fingertip. Disposable test strips are an essential component of invasive glucometers. These strips are designed to react with glucose in the blood and contain enzymes that facilitate an electrochemical reaction. Once the skin is punctured using the lancing device, a small droplet of blood is collected on the fingertip. The user then applies this blood sample to the designated area on the test strip. The blood sample on the test strip undergoes a chemical reaction with the enzymes present on the strip. This reaction generates an electric current that is proportional to the concentration of glucose in the blood.

Based on Region, Abu Dhabi region held the largest share in the UAE Glucometers Market. There are targeted awareness and education programs in the Abu Dhabi region to educate individuals about the importance of diabetes management and monitoring, it could drive the adoption of glucometers. Major healthcare providers, distributors, or manufacturers of glucometers have a strong presence at headquarters in Abu Dhabi, it could contribute to the dominance of the region in the market. The presence of research and development centers focused on healthcare technologies in Abu Dhabi may lead to the development and adoption of innovative glucometer solutions.

Some of the major companies operating in the UAE Glucometers Market include:

  • Abbott Laboratories, SA.
  • Medtronic Meta FZ-LLC
  • Roche Diagnostics Middle East FZCO
  • Morepen Laboratories UAE (Dr. Morepen)
  • Ascensia UAE
  • Beurer UAE
  • Dexcom UAE

 

Download free Sample Report

Customers can also request 10% free customization on this report


“Certain areas, particularly in Dubai, are projected to exert significant demand for Glucometers. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the UAE Glucometers Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

UAE Glucometers Market By Product Type (Self Glucose Monitoring Glucometers, Continuous Glucose Monitoring Glucometers), By Technique (Invasive, Non-Invasive), By Type (Wearable, Non-Wearable), By Distribution Channel (Hospital Pharmacies, Retail Outlet, Online, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Home Care, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE Glucometers Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in UAE Glucometers Market.


Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News